annual cash & cash equivalents:
$303.24M+$176.79M(+139.81%)Summary
- As of today (May 24, 2025), AMED annual cash & cash equivalents is $303.24 million, with the most recent change of +$176.79 million (+139.81%) on December 31, 2024.
- During the last 3 years, AMED annual cash & cash equivalents has risen by +$260.55 million (+610.27%).
- AMED annual cash & cash equivalents is now at all-time high.
Performance
AMED Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$284.88M-$18.36M(-6.05%)Summary
- As of today (May 24, 2025), AMED quarterly cash & cash equivalents is $284.88 million, with the most recent change of -$18.36 million (-6.05%) on March 31, 2025.
- Over the past year, AMED quarterly cash & cash equivalents has increased by +$176.65 million (+163.21%).
- AMED quarterly cash & cash equivalents is now -6.05% below its all-time high of $303.24 million, reached on December 31, 2024.
Performance
AMED quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AMED Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +139.8% | +163.2% |
| 3 y3 years | +610.3% | +320.0% |
| 5 y5 years | +901.0% | +63.0% |
AMED Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +648.0% | -6.0% | +1486.5% |
| 5 y | 5-year | at high | +901.0% | -6.0% | +1486.5% |
| alltime | all time | at high | >+9999.0% | -6.0% | >+9999.0% |
AMED Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $284.88M(-6.1%) |
| Dec 2024 | $303.24M(+139.8%) | $303.24M(+23.5%) |
| Sep 2024 | - | $245.45M(+63.8%) |
| Jun 2024 | - | $149.88M(+38.5%) |
| Mar 2024 | - | $108.23M(-14.4%) |
| Dec 2023 | $126.45M(+211.9%) | $126.45M(+61.9%) |
| Sep 2023 | - | $78.11M(-18.1%) |
| Jun 2023 | - | $95.38M(+92.9%) |
| Mar 2023 | - | $49.44M(+21.9%) |
| Dec 2022 | $40.54M(-5.0%) | $40.54M(+125.8%) |
| Sep 2022 | - | $17.96M(-32.4%) |
| Jun 2022 | - | $26.57M(-60.8%) |
| Mar 2022 | - | $67.83M(+58.9%) |
| Dec 2021 | $42.69M(-47.8%) | $42.69M(-65.7%) |
| Sep 2021 | - | $124.46M(+35.8%) |
| Jun 2021 | - | $91.65M(+18.5%) |
| Mar 2021 | - | $77.34M(-5.5%) |
| Dec 2020 | $81.81M(+170.0%) | $81.81M(-27.5%) |
| Sep 2020 | - | $112.90M(-36.3%) |
| Jun 2020 | - | $177.28M(+1.4%) |
| Mar 2020 | - | $174.76M(+476.9%) |
| Dec 2019 | $30.29M(+49.8%) | $30.29M(+45.9%) |
| Sep 2019 | - | $20.76M(+49.3%) |
| Jun 2019 | - | $13.90M(+31.7%) |
| Mar 2019 | - | $10.55M(-47.8%) |
| Dec 2018 | $20.23M(-76.6%) | $20.23M(+44.4%) |
| Sep 2018 | - | $14.01M(-45.9%) |
| Jun 2018 | - | $25.90M(-78.4%) |
| Mar 2018 | - | $120.00M(+39.0%) |
| Dec 2017 | $86.36M(+186.0%) | $86.36M(+30.6%) |
| Sep 2017 | - | $66.11M(+11.7%) |
| Jun 2017 | - | $59.16M(+22.4%) |
| Mar 2017 | - | $48.33M(+60.1%) |
| Dec 2016 | $30.20M(+9.8%) | $30.20M(+238.7%) |
| Sep 2016 | - | $8.91M(-10.6%) |
| Jun 2016 | - | $9.97M(+27.4%) |
| Mar 2016 | - | $7.82M(-71.6%) |
| Dec 2015 | $27.50M(+242.4%) | $27.50M(-51.8%) |
| Sep 2015 | - | $57.05M(+71.8%) |
| Jun 2015 | - | $33.20M(+960.1%) |
| Mar 2015 | - | $3.13M(-61.0%) |
| Dec 2014 | $8.03M(-53.6%) | $8.03M(+44.9%) |
| Sep 2014 | - | $5.54M(-50.6%) |
| Jun 2014 | - | $11.22M(+295.2%) |
| Mar 2014 | - | $2.84M(-83.6%) |
| Dec 2013 | $17.30M(+19.0%) | $17.30M(-60.3%) |
| Sep 2013 | - | $43.63M(+44.9%) |
| Jun 2013 | - | $30.12M(+329.0%) |
| Mar 2013 | - | $7.02M(-51.7%) |
| Dec 2012 | $14.54M(-69.7%) | $14.54M(-62.8%) |
| Sep 2012 | - | $39.11M(+5.2%) |
| Jun 2012 | - | $37.16M(-10.0%) |
| Mar 2012 | - | $41.29M(-14.0%) |
| Dec 2011 | $48.00M(-60.1%) | $48.00M(+62.9%) |
| Sep 2011 | - | $29.46M(+4.7%) |
| Jun 2011 | - | $28.13M(-81.1%) |
| Mar 2011 | - | $148.87M(+23.8%) |
| Dec 2010 | $120.30M | $120.30M(+3.7%) |
| Jun 2010 | - | $116.03M(+41.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $81.98M(+137.7%) |
| Dec 2009 | $34.48M(+1111.3%) | $34.48M(-23.6%) |
| Sep 2009 | - | $45.16M(+4929.0%) |
| Jun 2009 | - | $898.00K(-96.5%) |
| Mar 2009 | - | $25.65M(+800.9%) |
| Dec 2008 | $2.85M(-94.9%) | $2.85M(-49.7%) |
| Sep 2008 | - | $5.66M(+241.2%) |
| Jun 2008 | - | $1.66M(-93.4%) |
| Mar 2008 | - | $25.24M(-55.1%) |
| Dec 2007 | $56.19M(-33.3%) | $56.19M(-15.6%) |
| Sep 2007 | - | $66.59M(-27.1%) |
| Jun 2007 | - | $91.34M(-15.0%) |
| Mar 2007 | - | $107.48M(+27.6%) |
| Dec 2006 | $84.22M(+388.8%) | $84.22M(+754.6%) |
| Sep 2006 | - | $9.86M(+23.9%) |
| Jun 2006 | - | $7.96M(-16.0%) |
| Mar 2006 | - | $9.48M(-45.0%) |
| Dec 2005 | $17.23M(-80.8%) | $17.23M(-17.0%) |
| Sep 2005 | - | $20.75M(-71.2%) |
| Jun 2005 | - | $72.06M(-8.7%) |
| Mar 2005 | - | $78.92M(-12.0%) |
| Dec 2004 | $89.68M(+201.1%) | $89.68M(-3.8%) |
| Sep 2004 | - | $93.18M(+318.2%) |
| Jun 2004 | - | $22.28M(-8.5%) |
| Mar 2004 | - | $24.34M(-18.3%) |
| Dec 2003 | $29.78M(+512.6%) | $29.78M(+195.9%) |
| Sep 2003 | - | $10.06M(-21.4%) |
| Jun 2003 | - | $12.80M(+53.5%) |
| Mar 2003 | - | $8.34M(+71.6%) |
| Dec 2002 | $4.86M(+38.3%) | $4.86M(-56.2%) |
| Sep 2002 | - | $11.09M(+11.8%) |
| Jun 2002 | - | $9.92M(+325.1%) |
| Mar 2002 | - | $2.33M(-33.6%) |
| Dec 2001 | $3.52M(-49.5%) | $3.52M(+5.1%) |
| Sep 2001 | - | $3.35M(-12.5%) |
| Jun 2001 | - | $3.82M(-68.7%) |
| Mar 2001 | - | $12.21M(+75.2%) |
| Dec 2000 | $6.97M(+388.9%) | $6.97M(+50.5%) |
| Sep 2000 | - | $4.63M(-3.2%) |
| Jun 2000 | - | $4.78M(+277.3%) |
| Mar 2000 | - | $1.27M(+121.5%) |
| Dec 1999 | $1.43M(+149.1%) | - |
| Dec 1998 | $572.00K(-85.9%) | $572.00K(+14.4%) |
| Jun 1998 | - | $500.00K(-61.5%) |
| Mar 1998 | - | $1.30M(-68.1%) |
| Dec 1997 | $4.07M(+268.6%) | $4.07M(+50.7%) |
| Sep 1997 | - | $2.70M(+8.0%) |
| Jun 1997 | - | $2.50M(+92.3%) |
| Mar 1997 | - | $1.30M(+17.7%) |
| Dec 1996 | $1.10M(+22.7%) | $1.10M(-54.0%) |
| Sep 1996 | - | $2.40M(+500.0%) |
| Jun 1996 | - | $400.00K(0.0%) |
| Mar 1996 | - | $400.00K(-55.6%) |
| Dec 1995 | $900.00K(+350.0%) | $900.00K(+50.0%) |
| Sep 1995 | - | $600.00K(+200.0%) |
| Jun 1995 | - | $200.00K(0.0%) |
| Dec 1994 | $200.00K(-81.8%) | $200.00K(-50.0%) |
| Jun 1994 | - | $400.00K(-42.9%) |
| Mar 1994 | - | $700.00K(-36.4%) |
| Dec 1993 | $1.10M | $1.10M |
FAQ
- What is Amedisys annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Amedisys?
- What is Amedisys annual cash & cash equivalents year-on-year change?
- What is Amedisys quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Amedisys?
- What is Amedisys quarterly cash & cash equivalents year-on-year change?
What is Amedisys annual cash & cash equivalents?
The current annual cash & cash equivalents of AMED is $303.24M
What is the all time high annual cash & cash equivalents for Amedisys?
Amedisys all-time high annual cash & cash equivalents is $303.24M
What is Amedisys annual cash & cash equivalents year-on-year change?
Over the past year, AMED annual cash & cash equivalents has changed by +$176.79M (+139.81%)
What is Amedisys quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of AMED is $284.88M
What is the all time high quarterly cash & cash equivalents for Amedisys?
Amedisys all-time high quarterly cash & cash equivalents is $303.24M
What is Amedisys quarterly cash & cash equivalents year-on-year change?
Over the past year, AMED quarterly cash & cash equivalents has changed by +$176.65M (+163.21%)